CDMO and Pharmaceutical Manufacturers

Where CDMO and Pharma Incubate Excellence

Explore the strategic advantages of Ontario as the ideal location for Contract Development Manufacturing Organizations (CDMOs) and pharmaceutical companies. With a rich heritage of manufacturing excellence and access to top talent and world-class research partners, Ontario empowers you to develop and produce groundbreaking molecules at scale. Foster the future of pharmaceutical manufacturing right here in Ontario, where your ambitions can thrive.

A measurable difference

$61.3B

in pharmaceuticals revenue in 2024

53.5%

of Canadian pharmaceutical employment

$11.2B

in goods exports

48.5%

of Canada’s total pharmaceutical firms

10

of the world’s top pharmaceutical companies by revenue are conducting clinical trials in Ontario

34,500

people employed in pharma

$2.46B

invested in R&D by Ontario’s research hospitals

Chart the Formula for Success in Ontario

Engage An Expert

Optimize growth in Competitive Business Environment

Maximize your potential in Ontario's high-quality pharmaceutical manufacturing sector, offering a competitive business environment tailored for end-to-end drug development and manufacturing operations. Take advantage of Ontario’s generous R&D tax credits which significantly reduce the after-tax cost of R&D expenditures, making it more cost-effective for large manufacturers and SMEs to innovate. Witness groundbreaking investments like OmniaBio’s $580+ million in a new biomanufacturing facility in Brampton, providing unparalleled opportunities for your company to thrive in the dynamic landscape of pharmaceutical innovation.

56.6%

of Canada’s pharma revenue in 2022

200 million

people within 2 hours flight from Toronto

Leverage Ontario's Strategic Location

Expand your CDMO business by partnering with a global clientele from Ontario. Benefit from access to top pharmaceutical companies and biotech startups and tap into major North American markets with 194+ million consumers within a day’s drive of the Greater Toronto Area. Take advantage of preferential access to global markets through 15 trade agreements for efficient distribution of your pharmaceutical products manufactured in Ontario.

Exceptional Talent and Ecosystem

Unlock Ontario's pharmaceutical potential by harnessing its robust life sciences ecosystem. Benefit from top-tier talent and R&D support from world-leading academic and research institutions. Ontario hosts world-renowned research centres, hospitals and clinics such as the Ontario Cancer Institute, SickKids, Mount Sinai and the London Health Sciences Centre offering invaluable resources in areas cancer research, regenerative medicine, diagnostic imaging, and neuroscience. Collaborate with CDMOs to accelerate drug development through strategic partnerships, ensuring efficient progress towards your goals.

OmniaBio Inc. will be a game-changer for Ontario and Canada. It will provide missing infrastructure to allow Ontario and Canadian cell and gene companies to remain here, while also attracting foreign companies. Cell and gene therapy is Canada’s opportunity to be global leaders in life sciences. Investing in manufacturing is a key driver, and we’re grateful to Invest Ontario for its leadership and foresight.

Michael May

Chair, OmniaBio Inc.

In good company

OmniaBio

Invest Ontario is supporting OmniaBio Inc. in launching a new biomanufacturing facility that will catalyze Ontario life sciences jobs and innovation while advancing pioneering medicine with the potential to cure, not just treat, many forms of cancers, cardiovascular diseases, Parkinson’s and diabetes.

Roche Canada

Invest Ontario is proud to partner with Roche Canada to support the establishment of a Global Informatics Hub in Mississauga, Ontario. This investment of more than $130 million CAD over five years will create up to 250 new jobs in innovative areas like artificial intelligence (AI), machine learning, computational biology and data analytics.